Suchergebnisse - "Laird, Glen"

PubPharm (21)

1

A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints

enthalten in: Statistics in medicine | 2024

von Zhang, W. | Laird, G. | Chen, J. | +1

2

A confirmatory basket design considering non-inferiority and superiority testing

enthalten in: Journal of biopharmaceutical statistics | 2024

von Zhang, Y. | Chu, C. | Beckman, R. | +3

3

A Bayesian phase II proof‐of‐concept design for clinical trials with longitudinal endpoints

enthalten in: Statistics in Medicine | 2024

von Zhang, W. | Laird, G. | Chen, J. | +1

4

Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies

enthalten in: BMJ open respiratory research | 2021

von Bresnick, K. | Arteaga-Solis, E. | Millar, S. | +2

5

Beyond exposure-response : A tutorial on statistical considerations in dose-ranging studies

enthalten in: Clinical and translational science | 2021

von Laird, G. | Xu, L. | Liu, M. | +1

6

Design and analysis of drop-the-losers studies using binary endpoints in the rare disease setting

enthalten in: Journal of biopharmaceutical statistics | 2021

von Jazić, I. | Liu, X. | Laird, G.

7

Design and analysis of drop-the-losers studies using binary endpoints in the rare disease setting

enthalten in: Journal of biopharmaceutical statistics | 2021

von Jazić, I. | Liu, X. | Laird, G.

8

Beyond exposure‐response : A tutorial on statistical considerations in dose‐ranging studies

enthalten in: Clinical and Translational Science | 2021

von Laird, G. | Xu, L. | Liu, M. | +1

9

Bayesian additive decision trees of biomarker by treatment interactions for predictive biomarker detection and subgroup identification

enthalten in: Journal of biopharmaceutical statistics | 2018

von Zhao, Y. | Zheng, W. | Zhuo, D. | +5

10

Goodness-of-fit test for proportional subdistribution hazards model

enthalten in: Statistics in medicine | 2013

von Zhou, B. | Fine, J. | Laird, G.